This three-year fellowship offers a unique opportunity to conduct high-impact fundamental research within a premier industrial setting. You will investigate the complex interplay between chronic inflammation and Myeloid Dysplastic Syndrome (MDS), aiming to uncover novel mechanisms that drive disease progression and therapeutic resistance. This project is supported by the Hematology R&D Small Molecular Discovery group of AstraZeneca that works across areas from early-stage drug discovery to late-stage clinical development. You will receive support from the AZ’s Bioinformatics Group and Sequencing Core to dissect the inflammasome-driven mechanisms underlying MDS development and translate these insights into transformative drug discovery efforts to deliver better therapies to patients. This project will explore inflammasome-targeted strategies in MDS through in vitro and in vivo studies to enable novel drug development. The Postdoctoral Fellow will partner with cross-functional AZ scientists and closely aligned academic mentors to build advanced models, identify new targets and optimize therapeutics for improved efficacy and safety. Your research will focus on how inflammatory signaling affects MDS cells both intrinsically and extrinsically. You will be at the forefront of: Characterizing inflammatory drivers of clonal evolution in MDS. Use innovative approaches to define how targeting inflammatory pathways alters myeloid signaling and disease biology in MDS cells. Translating bench-side discoveries into actionable therapeutic strategies. The Postdoc role will report to Haiming Xu (Associate Principal Scientist), and be supported by Ye Xu (Associate Principal Scientist) and Sungmi Park-Chouinard (Associate Director) at AstraZeneca. Additionally, you'll also receive mentorship and guidance from exceptional academic mentors, Stephanie Halene, M.D., Arthur H. and Isabel Bunker Professor of Hematology, Yale University School of Medicine; Richard Flavell, PhD, FRS., Stering Professor of Immunobiology, Yale University School of Medicine; and Gabriel Ghiaur, MD, PhD., Associate Professor of Oncology, Johns Hopkins School of Medicine during the 3-year program. Our Postdoctoral Fellow will investigate the role of inflammatory signaling in the pathogenesis and progression of MDS, focusing on both cell-intrinsic mechanisms and microenvironment-mediated effects.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Entry Level
Education Level
Ph.D. or professional degree